According to the results, either phosphorylation of STAT3 or prosurvival protein survivin expression could be more downregulated by combined treatment groups in both cell lines, suggesting the function of AS enhancing DTX-induced antitumor activity through suppression of prosurvival proteins in NSCLC. This evidence concerns the gene BIRC5 and non-small cell lung carcinoma.